Why DexCom's Stock Is Trading Higher Today

DexCom, Inc. DXCM shares are trading higher after the company reported better-than-expected Q2 EPS and sales results and issued FY21 sales guidance above estimates.

DexCom reported quarterly earnings of $0.76 per share which beat the analyst estimate of $0.45 and sales results of $595.10 million which beat the analyst consensus estimate of $551.27 million.

The company also issued full-year sales guidance in the range of $2.35 billion and $2.4 billion which is above the $2.34 billion estimate.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems in the United States and internationally.

DexCom's stock was trading about 3.5% higher afterhours at $472.13 per share on Thursday. The stock set a new 52-week high of $472.13 and has a 52-week low of $305.63.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsGuidanceMoversTrading Ideaswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!